December 2016 FDA Recall Drug by Amneal Pharmaceuticals Llc
D-0693-2017 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Amneal Pharmaceuticals Llc on December 12, 2016 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0693-2017

Reason for Recall
Failed Dissolution Specifications
Initiated
12-12-2016
Reported
05-10-2017
Quantity
105,215 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amneal Pharmaceuticals LLC
Nationwide within the US and PR
Rabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65162-0724-03), b) 90-count bottle (NDC 65162-0724-09), Rx Only, Manufactured by Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad INDIA 382220, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ 08807

Batch or Lot Expiration Information

Lot# : a) AR151324, AR151322, AR151325, Exp. 9/2017; AR160730A, AR160731A, AR160732A, Exp. 05/2018. b) AR151324, AR151322, AR151325, Exp. 9/2017; AR160730B, 5/2018.